Journey to top performance: a multipronged quality improvement approach to reducing cardiac surgery mortality

S Jacob Scheinerman1, Yosef D Dlugacz, Alan R Hartman

  • 1Cardiothoracic Surgery, Long Island Jewish Medical Center, New Hyde Park, New York, USA.

Insights

Long Island Jewish Medical Center reduced cardiac surgery mortality by redesigning its program. This led to sustained, significantly lower rates compared to the state average, demonstrating the impact of quality improvement initiatives.

Area of Science:

  • Cardiovascular Surgery
  • Quality Improvement in Healthcare
  • Health Services Research

Background:

  • In 2006, Long Island Jewish Medical Center observed elevated cardiac surgery mortality rates for valve and valve/coronary artery bypass graft procedures compared to New York State averages.
  • This prompted an internal evaluation of the hospital's cardiac surgery program.

Purpose of the Study:

  • To investigate the reasons for higher-than-expected cardiac surgery mortality rates.
  • To implement changes to reduce cardiac surgery mortality and improve patient outcomes.

Main Methods:

  • A comprehensive evaluation of the cardiac surgery program was conducted.
  • Interventions were implemented across preoperative, intraoperative, and postoperative care phases.
  • A cardiac surgery quality management program was enhanced.

Main Results:

  • From 2009-2011, Long Island Jewish Medical Center achieved the lowest risk-adjusted mortality rate in New York State for adult valve repair/replacement and valve/coronary artery bypass graft surgeries.
  • These significantly lower mortality rates have been sustained over three reporting periods.

Conclusions:

  • Commitment to clinical excellence and continuous performance assessment can significantly reduce cardiac surgery mortality.
  • The redesign of the cardiac surgery program at Long Island Jewish Medical Center resulted in widespread improvements and cultural change, leading to sustained low mortality rates.
Abstract

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
438
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
695
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
767
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
483
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
423
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
490